Novel peptide ligand directs liposomes toward EGF-R high-expressing cancer cells in vitro and in vivo

FASEB Journal

Volumn 23, Issue 5, 2009, Pages 1396-1404

  Song, Shuxian ^a   Liu, Dan ^a   Peng, Jinliang ^a   Deng, Hongwei ^a   Guo, Yan ^a   Xu, Lisa X ^a   Miller, Andrew D ^b,c   Xu, Yuhong ^a  

^a SHANGHAI JIAO TONG UNIVERSITY   (China)

^b IMPERIAL COLLEGE LONDON   (United Kingdom)

^c ImuThes Ltd   (United Kingdom)

Author keywords

AutoDock; Computer aided design; Epidermal growth factor; Lipid; PEG; Proteomic code

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR; LEUCYLALANYLARGINYLLEUCYLLEUCYLTHREONINE; LIPOSOME; MACROGOL; PEPTIDE; PEPTIDE LIBRARY; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER CELL; COMPUTER AIDED DESIGN; CONTROLLED STUDY; CRYSTAL STRUCTURE; DRUG CONJUGATION; DRUG DELIVERY SYSTEM; DRUG SCREENING; ENDOCYTOSIS; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; TUMOR XENOGRAFT;

ANIMALS; ANTINEOPLASTIC AGENTS; CELL LINE, TUMOR; COMPUTER SIMULATION; COMPUTER-AIDED DESIGN; FLOW CYTOMETRY; HUMANS; LIGANDS; LIPOSOMES; MICE; MICROSCOPY, FLUORESCENCE; MODELS, MOLECULAR; OLIGOPEPTIDES; PEPTIDE LIBRARY; PHOSPHATIDYLETHANOLAMINES; RECEPTOR, EPIDERMAL GROWTH FACTOR;

EID: 69949164681     PISSN: 08926638     EISSN: 15306860     Source Type: Journal    
DOI: 10.1096/fj.08-117002     Document Type: Article

References (47)

1. Gabizon, A., Catane, R., Uziely, B., Kaufman, B., Safra, T., Cohen, R., Martin, F., Huang, A., and Barenholz, Y. (1994) Prolonged circulation time and enhanced accumulation in malignant exudates of doxorubicin encapsulated in polyethylene-glycol coated liposomes. Cancer Res. 54, 987-992 (Pubitemid 24085451)
2. Maruyama, K., Takizawa, T., Yuda, T., Kennel, S. J., Huang, L., and Iwatsuru, M. (1995) Targetability of novel immunoliposomes modified with amphipathic poly(ethylene glycol)s conjugated at their distal terminals to monoclonal antibodies. Biochim. Biophys. Acta 1234, 74-80
3. Park, J. W., Hong, K., Carter, P., Asgari, H., Guo, L. Y., Keller, G. A., Wirth, C., Shalaby, R., Kotts, C., Wood, W. I., Papahadjopoulos, D., and Benz, C. C. (1995) Development of anti-p185HER2 immunoliposomes for cancer therapy. Proc. Natl. Acad. Sci. U. S. A. 92, 1327-1331
4. Goren, D., Horowitz, A. T., Zalipsky, S., Woodle, M. C., Yarden, Y., and Gabizon, A. (1996) Targeting of stealth liposomes to erbB-2 (Her/2) receptor: in vitro and in vivo studies. Br. J. Cancer 74, 1749-1756 (Pubitemid 26401894)
5. Lopes de Menezes, D. E., Pilarski, L. M., and Allen, T. M. (1998) In vitro and in vivo targeting of immunoliposomal doxorubicin to human B-cell lymphoma. Cancer Res. 58, 3320-3330
6. Matsumura, Y., Gotoh, M., Muro, K., Yamada, Y., Shirao, K., Shimada, Y., Okuwa, M., Matsumoto, S., Miyata, Y., Ohkura, H., Chin, K., Baba, S., Yamao, T., Kannami, A., Takamatsu, Y., Ito, K., and Takahashi, K. (2004) Phase I and pharmacokinetic study of MCC-465, a doxorubicin (DXR) encapsulated in PEG immunoliposome, in patients with metastatic stomach cancer. Ann. Oncol. 15, 517-525 (Pubitemid 38444560)
7. Lee, R. J., and Low, P. S. (1995) Folate-mediated tumor cell targeting of liposome-entrapped doxorubicin in vitro. Biochim. Biophys. Acta 1233, 134-144
8. Gabizon, A., Horowitz, A. T., Goren, D., Tzemach, D., Shmeeda, H., and Zalipsky, S. (2003) In vivo fate of folate-targeted polyethylene-glycol liposomes in tumor-bearing mice. Clin. Cancer Res. 9, 6551-6559 (Pubitemid 38031844)
9. Terada, T., Mizobata, M., Kawakami, S., Yabe, Y., Yamashita, F., and Hashida, M. (2006) Basic fibroblast growth factor-binding peptide as a novel targeting ligand of drug carrier to tumor cells. J. Drug Target. 14, 536-545 (Pubitemid 44592887)
10. Schiffelers, R. M., Koning, G. A., ten Hagen, T. L., Fens, M. H., Schraa, A. J., Janssen, A. P., Kok, R. J., Molema, G., and Storm, G. (2003) Anti-tumor efficacy of tumor vasculature-targeted liposomal doxorubicin. J. Control. Release 91, 115-122
11. Salomon, D. S., Brandt, R., Ciardiello, F., and Normanno, N. (1995) Epidermal growth factor-related peptides and their receptors in human malignancies. Crit. Rev. Oncol. Hematol. 19, 183-232
12. Lutsenko, S. V., Feldman, N. B., and Severin, S. E. (2002) Cytotoxic and antitumor activities of doxorubicin conjugates with the epidermal growth factor and its receptor-binding fragment. J. Drug Target. 10, 567-571
13. Jinno, H., Ueda, M., Ozawa, S., Kikuchi, K., Ikeda, T., Enomoto, K., and Kitajima, M. (1996) Epidermal growth factor receptor-dependent cytotoxic effect by an EGF-ribonuclease conjugate on human cancer cell lines: a trial for less immunogenic chimeric toxin. Cancer Chemother. Pharmacol. 38, 303-308 (Pubitemid 26226295)
14. Kullberg, E. B., Nestor, M., and Gedda, L. (2003) Tumor-cell targeted epiderimal growth factor liposomes loaded with boronated acridine: uptake and processing. Pharm. Res. 20, 229-236 (Pubitemid 36269729)
15. Chen, P., Mrkobrada, M., Vallis, K. A., Cameron, R., Sandhu, J., Hendler, A., and Reilly, R. M. (2002) Comparative antiproliferative effects of (111)In-DTPA-hEGF, chemotherapeutic agents and gamma-radiation on EGFR-positive breast cancer cells. Nucl. Med. Biol. 29, 693-699 (Pubitemid 35266670)
16. Blessing, T., Kursa, M., Holzhauser, R., Kircheis, R., and Wagner, E. (2001) Different strategies for formation of pegylated EGF-conjugated PEI/DNA complexes for targeted gene delivery. Bioconjug. Chem. 12, 529-537 (Pubitemid 32696226)
17. Mamot, C., Drummond, D. C., Greiser, U., Hong, K., Kirpotin, D. B., Marks, J. D., and Park, J. W. (2003) Epidermal growth factor receptor (EGFR) -targeted immunoliposomes mediate specific and efficient drug delivery to EGFR- and EGFRvIII-overexpressing tumor cells. Cancer Res. 63, 3154-3161 (Pubitemid 36735867)
18. Mamot, C., Drummond, D. C., Noble, C. O., Kallab, V., Guo, Z., Hong, K., Kirpotin, D. B., and Park, J. W. (2005) Epidermal growth factor receptor-targeted immunoliposomes significantly enhance the efficacy of multiple anticancer drugs in vivo. Cancer Res. 65, 11631-11638 (Pubitemid 41821723)
19. Mamot, C., Ritschard, R., Kung, W., Park, J. W., Herrmann, R., and Rochlitz, C. F. (2006) EGFR-targeted immunoliposomes derived from the monoclonal antibody EMD72000 mediate specific and efficient drug delivery to a variety of colorectal cancer cells. J. Drug Target. 14, 215-223 (Pubitemid 43922062)
20. Heal, J. R., Roberts, G. W., Raynes, J. G., Bhakoo, A., and Miller, A. D. (2002) Specific interactions between sense and complementary peptides: the basis for the proteomic code. ChemBioChem 3, 136-151 (Pubitemid 36004488)
21. Ishida, T., Iden, D. L., and Allen, T. M. (1999) A combinatorial approach to producing sterically stabilized (Stealth) immunoliposomal drugs. FEBS Lett. 460, 129-133 (Pubitemid 29479257)
22. Mayer, L. D., Tai, L. C., Bally, M. B., Mitilenes, G. N., Ginsberg, R. S., and Cullis, P. R. (1990) Characterization of liposomal systems containing doxorubicin entrapped in response to pH gradients. Biochim. Biophys. Acta 1025, 143-151
23. Haran, G., Cohen, R., Bar, L. K., and Barenholz, Y. (1994) Transmembrane ammonium sulfate gradients in liposomes produce efficient and stable entrapment of amphipathic weak bases. Biochim. Biophys. Acta (1993) 1151, 201-215; erratum in Biochim. Biophys. Acta 1190, 197 (Pubitemid 24066280)
24. Morris, G. M., Goodsell, D. S., Halliday, R. S., Huey, R., Hart, W. E., Belew, R. K., and Olson, A. J. (1998) Automated docking using a Lamarckian genetic algorithm and an empirical binding free energy function. J. Comput. Chem. 19, 1639-1662 (Pubitemid 128590223)
25. Hetenyi, C., and van der Spoel, D. (2002) Efficient docking of peptides to proteins without prior knowledge of the binding site. Protein Sci. 11, 1729-1737 (Pubitemid 34663553)
26. Kamaly, N., Kalber, T., Ahmad, A., Oliver, M. H., So, P. W., Herlihy, A. H., Bell, J. D., Jorgensen, M. R., and Miller, A. D. (2008) Bimodal paramagnetic and fluorescent liposomes for cellular and tumor magnetic resonance imaging. Bioconjug. Chem. 19, 118-129 (Pubitemid 351213842)
27. Pérez-Soler, R. (2004) HER1/EGFR targeting: refining the strategy. Oncologist 9, 58-67
28. Schmidt, M., Vakalopoulou, E., Schneider, D. W., and Wels, W. (1997) Construction and functional characterization of scFv(14E1)-ETA: a novel, highly potent antibody-toxin specific for the EGF receptor. Br. J. Cancer 75, 1575-1584 (Pubitemid 27229046)
29. Liu, X., Tian, P., Yu, Y., Yao, M., Cao, X., and Gu, J. (2002) Enhanced antitumor effect of EGFR-targeted p21WAF-1 and GM-CSF gene transfer in the established murine hepatoma by peritumoral injection. Cancer Gene Ther. 9, 100-108 (Pubitemid 34052859)
30. Li, Z., Zhao, R., Wu, X., Sun, Y., Yao, M., Li, J., Xu, Y., and Gu, J. (2005) Identification and characterization of a novel peptide ligand of epidermal growth factor receptor for targeted delivery of therapeutics. FASEB J. 19, 1978-1985 (Pubitemid 41759743)
31. De Graaf, C., Pospisil, P., Pos, W., Folkers, G., and Vermeulen, N. P. (2005) Binding mode prediction of cytochrome p450 and thymidine kinase protein-ligand complexes by consideration of water and rescoring in automated docking. J. Med. Chem. 48, 2308-2318 (Pubitemid 40516425)
32. Rogers, J. P., Beuscher, A. E., 4th, Flajolet, M., McAvoy, T., Nairn, A. C., Olson, A. J., and Greengard, P. (2006) Discovery of protein phosphatase 2C inhibitors by virtual screening. J. Med. Chem. 49, 1658-1667
33. Bhakoo, A., Raynes, J. G., Heal, J. R., Keller, M., and Miller, A. D. (2004) De-novo design of complementary (antisense) peptide mini-receptor inhibitor of interleukin 18 (IL-18). Mol. Immunol. 41, 1217-1224 (Pubitemid 39346269)
34. Ma, G., Gallant, P., and McIntosh, L. (2007) Sensitivity characterization of a time-domain fluorescence imager: eXplore Optix. Appl. Opt. 46, 1650-1657 (Pubitemid 46659531)
35. Hsu, A. R., Hou, L. C., Veeravagu, A., Greve, J. M., Vogel, H., Tse, V., and Chen, X. (2006) In vivo near-infrared fluorescence imaging of integrin alphavbeta3 in an orthotopic glioblastoma model. Mol. Imaging Biol. 8, 315-323
36. Ke, S., Wen, X., Gurfinkel, M., Charnsangavej, C., Wallace, S., Sevick-Muraca, E. M., and Li, C. (2003) Near-infrared optical imaging of epidermal growth factor receptor in breast cancer xenografts. Cancer Res. 63, 7870-7875 (Pubitemid 37466721)
37. Mastrobattista, E., Koning, G. A., and Storm, G. (1999) Immunoliposomes for the targeted delivery of antitumor drugs. Adv. Drug Delivery Rev. 40, 103-127 (Pubitemid 29486607)
38. Gabizon, A. A., Shmeeda, H., and Zalipsky, S. (2006) Pros and cons of the liposome platform in cancer drug targeting. J. Liposome Res. 16, 175-183 (Pubitemid 44358991)
39. Koning, G. A., Morselt, H. W., Gorter, A., Allen, T. M., Zalipsky, S., Kamps, J. A., and Scherphof, G. L. (2001) Pharmacokinetics of differently designed immunoliposome formulations in rats with or without hepatic colon cancer metastases. Pharm. Res. 18, 1291-1298 (Pubitemid 32846322)
40. Koning, G. A., Morselt, H. W., Gorter, A., Allen, T. M., Zalipsky, S., Scherphof, G. L., and Kamps, J. A. (2003) Interaction of differently designed immunoliposomes with colon cancer cells and Kupffer cells: an in vitro comparison. Pharm. Res. 20, 1249-1257 (Pubitemid 36951850)
41. Derksen, J. T., Morselt, H. W., and Scherphof, G. L. (1988) Uptake and processing of immunoglobulin-coated liposomes by subpopulations of rat liver macrophages. Biochim. Biophys. Acta 971, 127-136 (Pubitemid 18228064)
42. Maruyama, K., Takahashi, N., Tagawa, T., Nagaike, K., and Iwatsuru, M. (1997) Immunoliposomes bearing poloethylene glycol-coupled Fab′ fragment show prolonged circulation time and high extravasation into targeted solid tumors in vivo. FEBS Lett. 413, 177-180 (Pubitemid 27348659)
43. Huwyler, J., Yang, J., and Pardridge, W. M. (1997) Receptor mediated delivery of daunomycin using immunoliposomes: pharmacokinetics and tissue distribution in the rat. J. Pharmacol. Exp. Ther. 282, 1541-1546 (Pubitemid 27408339)
44. Kamaly, N., Kalber, T., Thanou, M., Bell, J. D., and Miller, A. D. (2008) Biomodal paramagnetic and fluorescent liposomes for cellular and tumor magnetic resonance imaging. Bioconj. Chem. 19, 118-129 (Pubitemid 351213842)
45. Kirpotin, D. B., Drummond, D. C., Shao, Y., Shalaby, M. R., Hong, K., Nielsen, U. B., Marks, J. D., Benz, C. C., and Park, J. W. (2006) Antibody targeting of long-circulating lipidic nanoparticles does not increase tumor localization but does increase internalization in animal models. Cancer Res. 66, 6732-6740 (Pubitemid 44085631)
46. Sapra, P., Moase, E. H., Ma, J., and Allen, T. M. (2004) Improved therapeutic responses in a xenograft model of human B lymphoma (Namalwa) for liposomal vincristine versus liposomal doxorubicin targeted via anti-CD19 IgG2a or Fab′ fragments. Clin. Cancer Res. 10, 1100-1111 (Pubitemid 38198912)
47. Song, S., Liu, D., Peng, J., Sun, Y., Li, Z., Gu, J. R., and Xu, Y. (2008) Peptide ligand-mediated liposome distribution and targeting to EGFR expressing tumor in vivo. Int. J. Pharm. 363, 155-161